Meningitis-Linked Firm Broke Regulations

The drug-mixing firm linked to the nationwide fungal meningitis outbreak reportedly broke several state regulations governing the distribution of medication, according to emails revealed to Reuters on Saturday. The New England Compounding Center in Massachusetts allegedly sold drugs to physicians without requiring patient names or proof of prescription in addition to soliciting bulk orders of their products. The contanimated medication associated with the outbreak is a steroid from the company, which has put as many as 14,000 people at risk.